Phase II Study of Azacitidine in Myelofibrosis.
Phase of Trial: Phase II
Latest Information Update: 21 Jan 2011
At a glance
- Drugs Azacitidine (Primary)
- Indications Myelofibrosis
- Focus Therapeutic Use
- 21 Jan 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 09 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Dec 2007 The expected completion date for this trial is now 1 Dec 2008.